Net loss for Q1 2026 was $1.6 million, compared to $8.9 million in Q1 2025. Cash and cash equivalents were $1.8 million as of March 31, 2026, down from $7.6 million at year-end 2025. The company completed a 1-for-50 reverse stock split on May 8, 2026. Operations have shifted from the discontinued KPI-012/MSC-S platform to the development of the Researgency agentic AI platform. The company issued 2.1 million shares of Series AAA Preferred Stock in January 2026, raising $4.2 million in gross proceeds.